The ISPE 2016 Mid-year meeting committee invites student abstracts for oral presentation in the area of pharmacoepidemiology and drug safety. Student and recent graduates* who are lead author on the study can submit abstracts. Twelve student abstracts will be selected for presentation at the 2016 Mid-year meeting in Baltimore, MD which will take place April 10-12, 2016. The recipients of the selected abstracts will be offered a scholarship to help cover travel and accommodation fees.

The abstract submission module is now closed. Notification will be sent in January.

Important Dates
Deadline for Abstract Submission: November 13, 2015
Notification of Acceptances: January 2016

Submitting an Abstract

Guidelines for Abstract Submission
The content of the submitted abstracts must be related to theme of the conference. Suggested topics for abstract submission are:

  1. Adherence
  2. Benefit Risk Assessment, Communication and Evaluation
  3. Biologics
  4. Classic Pharmacoepidemiology
  5. Comparative Effectiveness Research
  6. Database Research
  7. Drug Utilization/Health Services Research
  8. Medical Devices
  9. Medications in Pregnancy
  10. Molecular Epidemiology/Biomarkers/Pharmacogenetics
  11. Pediatrics

The abstract must be single-spaced and in upper and lowercase letters (do not use all capital letters). The text must not exceed 300 words excluding title and author details.

Abstracts must follow the following format: Background (including Aim/Objective), Methods, Results and Conclusion. In scoring the abstract, importance will be given to all the sections of the abstract. Tables, graphs, and charts are NOT permitted in abstracts.

The title should be specific to the content. Use short titles and standard abbreviations (expand at its first instance). Do not include the presenting author's name or affiliation in the abstract: you will be able to fill this out separately on the submission form. Avoid reference to institution names, locations, or funding sources in the abstract.

All abstracts must be submitted in English only. Please carefully check all text for errors before submitting into the system as the quality of your submission may affect the outcome of the reviewers' scoring of your abstract. No edits will be allowed in the submitted abstracts for typing, spelling, or grammatical errors.

Abstracts Review Process and Presentation
All submitted abstracts will be reviewed by at least three reviewers and the reviewers’ decision is the final.

Only the corresponding author will be notified of acceptance or non-acceptance, and it is the corresponding author's responsibility to notify all other authors about the outcome of the reviewers' decision.

Notification of acceptance or non-acceptance will be sent in January 2016.

If multiple abstracts are submitted by the same corresponding author, only the highest scoring abstract will be considered.

Scholarship Application
Twelve scholarships (expense reimbursements) of up to $1000 each are available to allow the submitters of the twelve highest scoring abstracts to attend the 2016 ISPE Mid-year meeting in Baltimore. Scholarships may be awarded to contribute towards expenses associated with registration, lodging, and travel to the conference.

However, we will do our utmost to divide the available scholarships fairly between the winning abstract submitters. The abstract review process will be completely anonymous to ensure travel costs do not influence abstract scores.

Students from developing countries and those in genuine financial need are invited to submit an abstract.

*To qualify as a student/recent graduate (received a degree from an institution within the last 3 years from the meeting date), we require proof of your full time student or recent graduate status, either a letter from your Program Director stating the beginning and ending dates of your program, a photocopy of your student identification showing an ending date, or a photocopy of your graduation diploma showing the date you graduated. You will be asked to submit proof of student status after you have submitted your abstract and have been assigned an abstract number.